What’s New at the ETSP?
3:00 pm - 4:00 pm CDT
Background: The NINDS Epilepsy Therapy Screening Program (ETSP), is a preclinical screening program that provides researchers the opportunity to screen potential therapeutic agents in established rodent seizure models. Since its establishment, the ETSP has played a role in the development of several FDA-approved epilepsy drugs.
You Will Learn: This webinar will broadly discuss the scope of the ETSP and new models and assays available at the University of Utah.
Speaker Bio: This webinar is presented by Dr. Cameron Metcalf, a Research Assistant Professor in Pharmacology and Toxicology at the University of Utah. He is also a Co-Investigator and the Associate Director of the Anticonvulsant Drug Development Program. Dr. Metcalf’s primary research interests include the evaluation and advancement of novel therapies for the treatment of epilepsy and pain.